Depression is driven by imbalances in neurotransmission and neuronal plasticity, affecting key brain regions such as the prefrontal cortex and hippocampus. Ion channels are central regulators of these processes. Voltage-gated sodium channels such as Nav1.3 and Nav1.7 and potassium channels such as Kv1.1 and KCNQ2/3 control neuronal excitability, while calcium channels such as Cav2.2 support synaptic plasticity. GABA and NMDA receptors help regulate the excitatory–inhibitory balance that is frequently disrupted in depression.
Modulating ion channels involved in synaptic plasticity, neuronal excitability and neurotransmitter release may help restore balanced excitatory and inhibitory signaling and support the development of more selective depression therapeutics.
Our Depression Ion Channel Portfolio provides a targeted framework for profiling ion channels and receptor channels that regulate mood, cognition, neuronal excitability and synaptic function. By focusing on targets relevant to mood-related brain regions, the portfolio supports investigation of depression biology and the development of innovative therapies.
The panel covers sodium, potassium, calcium, GABA and glutamate receptor channels, enabling the evaluation of compounds intended to modulate mood regulation, neurotransmission and neuroplasticity.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top